Advertisement

Search Results for "Tacrolimus Nordic"

20:55 EDT 22nd May 2013 | BioPortfolio

Original Source: Tacrolimus/Sirolimus/Methotrexate Versus Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma

This trial is comparing whether using a drug called sirolimus for graft versus host disease (GVHD) prevention can decrease the chance of the participant's lymphoma relapsing after transplantation, compared to using a standard GVHD prevention regimen without sirolimus. Since mTOR inhibitors have anti-lymphoma activity, their use after transplantation may lead to a decreased risk of relapse and hence better transplantation outcome.

Matching Channels

Crohns Disease

Crohns Disease is a chronic inflammatory disease, affecting the whole of the alimentary tract from mouth to anus, and all layers of the gut wall. The most commonly affected sites are the terminal il...

Matching News

Sequential oral, topical tacrolimus benefits dermatitis

(HealthDay)—Sequential therapy with oral tacrolimus and topical tacrolimus may be an effective treatment for severe atopic dermatitis (AD), according to a pilot study published in the October issue...

Mothers taking tacrolimus can safely breastfeed

Breastfeeding does not increase blood levels of tacrolimus in infants born to women taking the drug, a new online study reveals (Clinical Journal of the American Society of Nephrology, 24 January 201...

Tacrolimus breast milk transfer concerns allayed

Breastfeeding mothers taking tacrolimus do not pass the immunosuppressant on to their babies when breastfeeding, study results show.

Clinical trial to study immunosuppressant tacrolimus against generics

A new study at the University of Cincinnati seeks to end the questions over generic-vs.-brand for a common immunosuppressive drug for transplant patients, tacrolimus.

Tacrolimus safe and effective for refractory ulcerative colitis

NEW YORK (Reuters Health) - Tacrolimus therapy can increase the likelihood of remission when ulcerative colitis (UC) won't respond to steroids, a new paper suggests.

Tacrolimus shows short-term efficacy in refractory ulcerative colitis

NEW YORK (Reuters Health) - A retrospective German study has demonstrated that tacrolimus may be an effective option for corticosteroid refractory ulcerative colitis patients.

Nordic Naturals introduces new softgel for cardiovascular health

US-based omega-3 supplements manufacturer Nordic Naturals has introduced Nordic CoQ10 Ubiquinol 100 mg softgel.

Bavarian Nordic A/S: Bavarian Nordic Applauds Reauthorization of Key U.S. Biodefense Programs

New Law Demonstrates the Government's Commitment to Develop and Purchase Medical Countermeasures KVISTGÅRD, Denmark - March 5, 2013 - Bavarian Nordic A/S (NASDAQ OMX: BAVA) today applauded the fin...

Matching PubMed Articles

Pharmacokinetics of tacrolimus converted from twice-daily formulation to once-daily formulation in Chinese stable liver transplant recipients.

Aim:To evaluate the pharmacokinetics of tacrolimus in Chinese stable liver transplant recipients converted from immediate release (IR) tacrolimus-based immunosuppression to modified release (MR) tacro...

Measurement and Compartmental Modeling of the Effect of CYP3A5 Gene Variation on Systemic and Intrarenal Tacrolimus Disposition.

We evaluated the hypothesis that cytochrome P450 3A5 (CYP3A5) expression can affect intrarenal tacrolimus accumulation. Tacrolimus was administered orally to 24 healthy volunteers who were selected on...

Is there any way to protect from tacrolimus-induced renal and pancreas injury?

BACKGROUND: The aim of this study was to explore effects of erythropoietin and pentoxifylline in tacrolimus-induced pancreatic beta cell and renal injury in rats. METHODS: Rats in group I were given s...

Pharmacokinetics for once-daily versus twice-daily tacrolimus formulations in de novo liver transplantation: A randomized, open-label trial.

Tacrolimus, a cornerstone immunosuppressant, is available as a twice-daily formulation (tacrolimus bid). A once-daily prolonged-release formulation (tacrolimus qd) has been developed. This 6-week, ran...

Managing the atazanavir-tacrolimus drug interaction in a renal transplant recipient.

Purpose The management of the drug interaction between atazanavir and tacrolimus in a renal transplant recipient is described. Summary A 53-year-old African-American man with human immunodeficiency vi...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement